Yesterday, the U.S. Olympic Committee withdrew its offer to have Boston host the 2024 Olympics. This followed six months of a combination of cheerleading and obfuscation from Boston 2024, the nonprofit that was managing the bid.
When nonprofit board members are doing damage to their responsibilities, it is sometimes up to the nonprofit’s stakeholders—employees, constituents, clients, and funders—to rein in out-of-control trustees.
To us, this latest decision by the Boy Scouts of America to stop discriminating against adult scout leaders who are openly gay seems fraught with predictable problems.
Billy Graham’s son Franklin thinks he has a solution to the potential problem of terrorist killings in the U.S.—end all Muslim immigration.
For the Red Cross, the lack of an updated transparency and communications system is, as Sen. Grassley implies on behalf of donors and the public, not acceptable. Clearly, its questioners are not just going to get tired and go away.
It’s election season, so Planned Parenthood is back under attack.
These 35 women, though many say there are more, have formed what one of them called “a sorrowful sisterhood” of victims at the hands of Bill Cosby.
Understanding the impact of Twitter and other social platforms has evolved from just seeing a follower count to really understanding the impact of what those followers can do to support a nonprofit mission.
Sandra Bland’s funeral was held in Lisle, Illinois on Saturday, but the controversy over the circumstances of her arrest and death still roils.
From Law360 to Moody’s, analysts look at what may happen in the aftermath of the ruling in New Jersey. Will hospitals around the country lose their property tax exemption?
In Illinois, nonprofits providing services to the state’s vulnerable populations still do not know whether or how much they will be reimbursed. Meanwhile, the childcare sector is once again the first to be seriously affected.
In the United States, more children die from cancer than any other disease, but the market is still too small for Big Pharma to involve themselves deeply in its research. Enter nonprofits.